Moleculin Biotech (MBRX) Share-based Compensation (2016 - 2025)
Moleculin Biotech (MBRX) reported Share-based Compensation of $459,000 for Q4 2025, up 7.5% from $427,000 a year earlier and up 51.5% from the prior quarter.
Powered by 
Analysis
Moleculin Biotech (MBRX) Share-based Compensation (2016 - 2025) Analysis & Trends
For FY2025, Moleculin Biotech posted Share-based Compensation of $1.66 million, down 3.6% from FY2024.
- Share-based Compensation has declined for four consecutive years, with a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $1.73 million in FY2024 (-13.0%), $1.98 million in FY2023 (-12.8%), $2.28 million in FY2022 (-4.1%) and $2.37 million in FY2021 (+41.3%).
- Five-year quarterly Share-based Compensation spans a low of $303,000 in Q3 2025 and a high of $979,000 in Q3 2021.
- Year over year, Share-based Compensation gained in 1 of the last eight quarters, with an average decline of 8.5%.
- The high point for year-over-year Share-based Compensation in five years was Q3 2021 (growth of 112.8%); the low point was Q3 2023 (a decline of 29.5%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $303,000 (Q3 2025), $417,000 (Q2 2025) and $485,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Moleculin Biotech | 3.24 Mn | 3.24 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 459,000.00 |
| Sep 30, 2025 | 303,000.00 |
| Jun 30, 2025 | 417,000.00 |
| Mar 31, 2025 | 485,000.00 |
| Dec 31, 2024 | 427,000.00 |
| Sep 30, 2024 | 353,000.00 |
| Jun 30, 2024 | 453,000.00 |
| Mar 31, 2024 | 493,000.00 |
| Dec 31, 2023 | 479,000.00 |
| Sep 30, 2023 | 493,000.00 |
| Jun 30, 2023 | 513,000.00 |
| Mar 31, 2023 | 499,000.00 |
| Dec 31, 2022 | 535,000.00 |
| Sep 30, 2022 | 699,000.00 |
| Jun 30, 2022 | 514,000.00 |
| Mar 31, 2022 | 527,000.00 |
| Dec 31, 2021 | 556,000.00 |
| Sep 30, 2021 | 979,000.00 |
| Jun 30, 2021 | 433,000.00 |
| Mar 31, 2021 | 405,000.00 |
API Access
Moleculin Biotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();